Clinical Trials
302
Active:4
Completed:51
Trial Phases
6 Phases
Early Phase 1:10
Phase 1:5
Phase 2:13
+3 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (174 trials with phase data)• Click on a phase to view related trials
Not Applicable
120 (69.0%)Phase 4
22 (12.6%)Phase 2
13 (7.5%)Early Phase 1
10 (5.7%)Phase 1
5 (2.9%)Phase 3
4 (2.3%)Early Detection of PDAC in Patients With Chronic Pancreatitis
Completed
- Conditions
- Chronic PancreatitisPDAC - Pancreatic Ductal Adenocarcinoma
- First Posted Date
- 2025-08-05
- Last Posted Date
- 2025-08-05
- Target Recruit Count
- 359
- Registration Number
- NCT07104864
- Locations
- 🇨🇳
the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China
Real-world Study Evaluating the Long-term Outcomes of Pegylated Interferon α-2b Treatment in the Families With Clusters of HBV Infection and Unfavorable Prognosis - A Prospective, Controlled, Multicenter, Cohort Study
Recruiting
- Conditions
- Hepatitis B, Chronic (CHB)Hepatitis BHepatitis B Virus (HBV)
- Interventions
- Drug: Peg IFN-α-2b
- First Posted Date
- 2025-07-22
- Last Posted Date
- 2025-07-22
- Target Recruit Count
- 1500
- Registration Number
- NCT07079150
- Locations
- 🇨🇳
First Affiliated Hospital of Xian Jiaotong University, Xi'an, Shaanxi, China
The Epidemic Status and Development Trend of Hepatitis C Virus Infection in Pregnant Women in Xi'an
Not yet recruiting
- Conditions
- HCV InfectionHCV Elimination
- First Posted Date
- 2025-04-30
- Last Posted Date
- 2025-04-30
- Target Recruit Count
- 200000
- Registration Number
- NCT06952036
Hypotension Prediction Index and Intraoperative Hypotension Incidence
Not Applicable
Not yet recruiting
- Conditions
- Intraoperative Hypotension
- First Posted Date
- 2025-04-04
- Last Posted Date
- 2025-04-04
- Target Recruit Count
- 100
- Registration Number
- NCT06909786
- Locations
- 🇨🇳
the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China
Bivalirudin with Prolonged Infusion During PCI Versus Heparin After Fibrinolytic Therapy
Not Applicable
Not yet recruiting
- Conditions
- ST-segment Elevation Myocardial Infarction (STEMI)
- Interventions
- First Posted Date
- 2025-03-06
- Last Posted Date
- 2025-03-06
- Target Recruit Count
- 2400
- Registration Number
- NCT06861374
- Prev
- 1
- 2
- 3
- 4
- 5
- 60
- Next
News
No news found